165 related articles for article (PubMed ID: 27264006)
21. Primary myelofibrosis: 2012 update on diagnosis, risk stratification, and management.
Tefferi A
Am J Hematol; 2011 Dec; 86(12):1017-26. PubMed ID: 22086865
[TBL] [Abstract][Full Text] [Related]
22. Prognostication in MF: from CBC to cytogenetics to molecular markers.
Zhou A; Oh ST
Best Pract Res Clin Haematol; 2014 Jun; 27(2):155-64. PubMed ID: 25189726
[TBL] [Abstract][Full Text] [Related]
23. Cytogenetic study in primary myelofibrosis at diagnosis: Clinical and histological association and impact on survival according to WHO 2017 classification in an Italian multicenter series.
Iurlo A; Palandri F; Maria Elli E; Cattaneo D; Bucelli C; Sciumè M; Vincelli D; Brioschi F; Auteri G; Croci GA; Guerneri S; Isimbaldi G; Sabattini E; Cortinovis I; Bossi A; Rosti V; Martino B; Baldini L; Gianelli U
Hematol Oncol; 2021 Feb; 39(1):123-128. PubMed ID: 32979286
[TBL] [Abstract][Full Text] [Related]
24. The prognostic relevance of serum lactate dehydrogenase and mild bone marrow reticulin fibrosis in essential thrombocythemia.
Mudireddy M; Barraco D; Hanson CA; Pardanani A; Gangat N; Tefferi A
Am J Hematol; 2017 May; 92(5):454-459. PubMed ID: 28211153
[TBL] [Abstract][Full Text] [Related]
25. Validation and comparison of contemporary prognostic models in primary myelofibrosis: analysis based on 334 patients from a single institution.
Tefferi A; Huang J; Schwager S; Li CY; Wu W; Pardanani A; Mesa RA
Cancer; 2007 May; 109(10):2083-8. PubMed ID: 17407134
[TBL] [Abstract][Full Text] [Related]
26. DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status.
Gangat N; Caramazza D; Vaidya R; George G; Begna K; Schwager S; Van Dyke D; Hanson C; Wu W; Pardanani A; Cervantes F; Passamonti F; Tefferi A
J Clin Oncol; 2011 Feb; 29(4):392-7. PubMed ID: 21149668
[TBL] [Abstract][Full Text] [Related]
27. Differential diagnosis of myelofibrosis based on WHO 2008 criteria: acute panmyelosis with myelofibrosis, acute megakaryoblastic leukemia with myelofibrosis, primary myelofibrosis and myelodysplastic syndrome with myelofibrosis.
Bae E; Park CJ; Cho YU; Seo EJ; Chi HS; Jang S; Lee KH; Lee JH; Lee JH; Suh JJ; Im HJ
Int J Lab Hematol; 2013 Dec; 35(6):629-36. PubMed ID: 23693053
[TBL] [Abstract][Full Text] [Related]
28. [Analysis of clinical features and prognosis of primary myelodysplastic syndromes with myelofibrosis patients].
Su T; Zhang PH; Xu ZF; Chen HS; Qin TJ; Zhang Y; Zhang HL; Fan LW; Pan LJ; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):378-82. PubMed ID: 22781796
[TBL] [Abstract][Full Text] [Related]
29. The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients.
Guglielmelli P; Lasho TL; Rotunno G; Score J; Mannarelli C; Pancrazzi A; Biamonte F; Pardanani A; Zoi K; Reiter A; Duncombe A; Fanelli T; Pietra D; Rumi E; Finke C; Gangat N; Ketterling RP; Knudson RA; Hanson CA; Bosi A; Pereira A; Manfredini R; Cervantes F; Barosi G; Cazzola M; Cross NC; Vannucchi AM; Tefferi A
Leukemia; 2014 Sep; 28(9):1804-10. PubMed ID: 24549259
[TBL] [Abstract][Full Text] [Related]
30. The evolution and clinical relevance of prognostic classification systems in myelofibrosis.
Bose P; Verstovsek S
Cancer; 2016 Mar; 122(5):681-92. PubMed ID: 26717494
[TBL] [Abstract][Full Text] [Related]
31. A compendium of cytogenetic abnormalities in myelofibrosis: molecular and phenotypic correlates in 826 patients.
Wassie E; Finke C; Gangat N; Lasho TL; Pardanani A; Hanson CA; Ketterling RP; Tefferi A
Br J Haematol; 2015 Apr; 169(1):71-6. PubMed ID: 25521305
[TBL] [Abstract][Full Text] [Related]
32. Transfusion-dependency at presentation and its acquisition in the first year of diagnosis are both equally detrimental for survival in primary myelofibrosis--prognostic relevance is independent of IPSS or karyotype.
Tefferi A; Siragusa S; Hussein K; Schwager SM; Hanson CA; Pardanani A; Cervantes F; Passamonti F
Am J Hematol; 2010 Jan; 85(1):14-7. PubMed ID: 20029953
[TBL] [Abstract][Full Text] [Related]
33. 20+ Years and alive with primary myelofibrosis: Phenotypic signature of very long-lived patients.
Penna D; Lasho TL; Finke CM; Vallapureddy RR; Hanson CA; Ketterling RP; Pardanani A; Gangat N; Tefferi A
Am J Hematol; 2019 Mar; 94(3):286-290. PubMed ID: 30516867
[TBL] [Abstract][Full Text] [Related]
34. Patients with post-essential thrombocythemia and post-polycythemia vera differ from patients with primary myelofibrosis.
Masarova L; Bose P; Daver N; Pemmaraju N; Newberry KJ; Manshouri T; Cortes J; Kantarjian HM; Verstovsek S
Leuk Res; 2017 Aug; 59():110-116. PubMed ID: 28601551
[TBL] [Abstract][Full Text] [Related]
35. [Clinical features and prognostic analysis of 75 primary myelofibrosis patients].
Yu Q; Xu L; Gao X; Xu W; Yan H; Wu W; Li J; Shen Z
Zhonghua Xue Ye Xue Za Zhi; 2014 Oct; 35(10):922-5. PubMed ID: 25339331
[TBL] [Abstract][Full Text] [Related]
36. Chronic idiopathic myelofibrosis: prognostic impact of myelofibrosis and clinical parameters on event-free survival in 122 patients who presented in prefibrotic and fibrotic stages. A retrospective study identifying subgroups of different prognoses by using the RECPAM method.
Kreft A; Weiss M; Wiese B; Choritz H; Buhr T; Büsche G; Georgii A
Ann Hematol; 2003 Oct; 82(10):605-11. PubMed ID: 14564478
[TBL] [Abstract][Full Text] [Related]
37. Abnormal (marker) chromosomes in two patients with acute myelofibrosis.
Mitus WJ; Coleman N; Kiossoglou KA
Arch Intern Med; 1969 Feb; 123(2):192-7. PubMed ID: 5763618
[No Abstract] [Full Text] [Related]
38. Increased mean platelet volume (MPV) is an independent predictor of inferior survival in patients with primary and secondary myelofibrosis.
Lucijanic M; Mitrovic Z; Cicic D; Prka Z; Pejsa V; Livun A; Stoos-Veic T; Romic Z; Zivkovic M; Lucijanic I; Fabris Z; Kusec R
Int J Hematol; 2018 Feb; 107(2):166-172. PubMed ID: 29022201
[TBL] [Abstract][Full Text] [Related]
39. High absolute basophil count is a powerful independent predictor of inferior overall survival in patients with primary myelofibrosis.
Lucijanic M; Livun A; Stoos-Veic T; Pejsa V; Jaksic O; Cicic D; Lucijanic J; Romic Z; Orehovec B; Aralica G; Miletic M; Kusec R
Hematology; 2018 May; 23(4):201-207. PubMed ID: 28906207
[TBL] [Abstract][Full Text] [Related]
40. Primary myelofibrosis: a detailed statistical analysis of the clinicopathological variables influencing survival.
Rupoli S; Da Lio L; Sisti S; Campanati G; Salvi A; Brianzoni MF; D'Amico S; Cinciripini A; Leoni P
Ann Hematol; 1994 Apr; 68(4):205-12. PubMed ID: 8003563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
